Allergan Ligand (ALRI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Allergan Ligand (ALRI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (37)	9/9/1997 8:55:00 PM
From: squetch	of 46

It seems you think WLA is better for diabetes, but a JNJ deal is better for long term development of retinoids/rexinoids b/c JNJ would broaden the uses. and speed development. >>Part of the diabetes deal could include development of the other retinoids which would be largely funded by JNJ<<Could JNJ and LGND decided to refund ALRI to do this? I think Bernie suggested this earlier. >>JNJ buyout would eliminate AGN and make it easier to structure the diabetes deal<< Would the diabetes deal be a risk to the regulators? I guess we will find out tomorrow. (:>) Stan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next